EX-16.1 2 ex_159578.htm EXHIBIT 16.1 ex_159578.htm

Exhibit 16.1

 

 

October 7, 2019

 

Securities and Exchange Commission

Washington, D.C. 20549

 

Commissioners:

 

We have read GeoVax Lab, Inc.‘s statements included under Item 4.01 of its Form 8-K filed on October 7, 2019 and we agree with such statements concerning our firm.

 

 

/s/ Wipfli LLP